SIGNABLOK, INC.
Homepage - SignaBlok
WORCESTER, United States · Founded 2015 · $9.4M raised
- Headquarters
- WORCESTER, Massachusetts
- Employees
- 1–10
- Founded
- 2015
- Website
- signablok.com
- Total Funding
- $9.4M
- Last Round
- $1.4M GrantDec 2025
- Rounds
- 13
About
R&D company with 13 SBIR/STTR awards from Department of Health and Human Services, Department of Defense.
Summary
SIGNABLOK, INC. is a Biotech company based in WORCESTER, United States, founded in 2015. It has raised $9.4M in total across 13 rounds, most recently a $1.4M Grant round in Dec 2025. Investors include Department of Health and Human Services and Checkmate Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2025
Sign up to see all 13 rounds
Grant — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/signablok-inc"><img src="https://indexed.vc/api/badge/company/signablok-inc" alt="SIGNABLOK, INC. on Indexed.vc" width="260" height="76" /></a>